Mixed D2/5-HT(2A) antagonism of cocaine-induced facilitation of brain stimulation reward

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 275-280

  Tsibulsky, Vladimir L ^a   Grocki, Shannon ^a   Dashevsky, Boris A ^a   Kehne, John H ^b   Schmidt, Christopher J ^b   Sorensen, Stephen M ^b   Frank, Robert A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Department of CNS Disorders Hoechst Marion Roussel I ^*  (United States)

Author keywords

5 HT(2A) receptor; Amphetamine; Cocaine; D2 receptor; Dopamine; Haloperidol; MDL 28,133A; Rat; Risperidone; Self stimulation; Serotonin; Ventral tegmental area

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MDL 28133; RISPERIDONE; RITANSERIN; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; MDL 28133A; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BEHAVIOR; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; FACILITATION; MONOAMINE NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; VENTRAL TEGMENTUM; ANIMAL; BRAIN; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HISTOLOGY; MALE; PHYSIOLOGY; SELF STIMULATION; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; REWARD; RISPERIDONE; SELF STIMULATION; SEROTONIN ANTAGONISTS;

EID: 0031987344     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00445-0     Document Type: Article

References (46)

1. Amit Z., Smith B. R., Gill K. Serotonin uptake inhibitors. Effects on motivated consummatory behaviors J. Clin. Psychiatry (Suppl.). 52:1991;55-60.
2. Beninger R. J., Hoffman D. C., Mazurski E. J. Receptor subtype-specific dopaminergic agents and conditioned behavior. Neurosci. Biobehav. Rev. 13:1989;113-122.
3. Bradberry C. W., Nobiletti J. B., Elsworth J. D., Murphy B., Jatlow P., Roth R. H. Cocaine and cocaethylene. Microdialysis comparison of brain drug levels and effects on dopamine and serotonin J. Neurochem. 60:1993;1429-1435.
4. Broderick P. A., Kornak E. P. J., Eng F., Wechsler R. Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat. Pharmacol. Biochem. Behav. 46:1993;715-722.
5. Broderick P. A. In vivo electrochemical studies of gradient effects of (SC) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats. Pharmacol. Biochem. Behav. 46:1993;973-984.
6. Calogero A. E., Gallucci W. T., Kling M. A., Chrousos G. P., Gold P. W. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 505:1989;7-11.
7. Carroll M. E., Lac S. T., Asencio M., Kragh R. Intravenous cocaine self-administration in rats is reduced by dietary l-tryptophan. Psychopharmacology (Berlin). 100:1990;293-300.
8. Carroll M. E., Lac S. T., Asencio M., Kragh R. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35:1990;237-244.
9. Cunningham K. A., Lakoski J. M. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording. Neuropsychopharmacology. 3:1990;41-50.
10. 2 antagonism differently affects apomorphine- and amphetamine-induced stereotyped behavior. Pharmacol. Biochem. Behav. 58:1997;565-572.
11. 2 antagonism of amphetamine-induced facilitation of brain stimulation reward. Pharmacol. Biochem. Behav. 52:1995;799-804.
12. 2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation. Pharmacol. Biochem. Behav. 19:1983;867-872.
13. 2) in several rat brain regions. Eur. J. Pharmacol. 238:1993;425-429.
14. 2A receptor antagonist MDL 100,907 on MDMA-induced locomotion stimulation in rats. Neuropsychopharmacology. 15:1996;116-124.
15. Kleven M. S., Woolverton W. L. Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol. Depend. 31:1993;149-158.
16. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
17. Lacosta S., Roberts D. C. S. MDL-72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 44:1993;161-165.
18. Levy A. D., Li Q. A., Kerr J. E., Rittenhhouse P. A., Milonas G., Cabrera T. M., Battalgia G., Alvarez Sanz M. C, Van de Kar L. D. Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. J. Pharmacol. Exp. Ther. 259:1991;495-500.
19. Leysen J. E., Gommeren W., Eens A., De Chaffoy De Coucelles D., Stoff J. C., Janssen P. A. J. Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther. 247:1988;661-670.
20. Loh E. A., Roberts D. C. S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berlin). 101:1990;262-266.
21. Mcgregor A., Lacosta S., Roberts D. C. S. l-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 43:1993;651-655.
22. 2 antagonist, attenuates craving for cocaine by rats. Pharmacol. Biochem. Behav. 46:1993;125-129.
23. Meert T. F., Janssen P. A. J. Ritanserin, a new therapeutic approach for drug abuse. Part 2. Effects on cocaine Drug Dev. Res. 25:1992;39-53.
24. Melis M. R., Argiolas A. Dopamine and sexual behavior. Neurosci. Biobehav. Rev. 19:1995;19-38.
25. 2 pKi values. J. Pharmacol. Exp. Ther. 251:1989;238-246.
26. 2a antagonist. Behav. Brain Res. 73:1995;163-167.
27. Nader M. A., Barett J. E. Effects of chlordiazepoxide, buspirone, and serotonin receptor agonists and antagonists on responses of squirrel monkeys maintained under second-order schedules of intramuscular cocaine injection or food presentation. Drug Dev. Res. 20:1990;5-17.
28. Nomikos G. G., Spyraki C. Effects of ritanserin on the rewarding properties of d-amphetamine, morphine and diazepam revealed by conditioned place preference in rats. Pharmacol. Biochem. Behav. 30:1988;853-858.
29. 3 mediated control of dopaminergic function. Psychopharmacology (Berlin) Suppl. 112:1993;S60-S67.
30. Parsons L. H., Justice J. B. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61:1993;1611-1619.
31. Peltier R., Schenk S. Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology (Berlin). 110:1993;390-394.
32. Peltier R. L., Emmett-Oglesby M. W., Thomas W. H., Schenk S. Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine. Pharmacol. Biochem. Behav. 48:1994;473-478.
33. Porrino L. J., Ritz M. C., Goodman N. L., Sharpe L. G., Kuhar M. J., Goldberg S. R. Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci. 45:1989;1529-1535.
34. Ramana S. V., Desiraju T. Investigation of influence of diazepam, valproate, cyproheptadine and cortisol on the rewarding ventral tegmental self-stimulation behavior. Ind. J. Physiol. Pharmacol. 33:1989;179-185.
35. Rapoza D., Woolverton W. L. Attenuation of the effects of cocaine on milk consumption in rats by dopamine antagonists. Pharmacol. Biochem. Behav. 40:1991;133-137.
36. Reith M. E. A. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol. 186:1990;327-330.
37. Richardson N. R., Roberts D. C. S. Fluoxetine pretreatment reduces breaking point on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci. 49:1991;833-840.
38. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219.
39. 1C receptor antagonists. Behav. Pharmacol. 4:1993;101-106.
40. Schechter M. D., Meehan S. M. Serotonergic medication of cocaine seizures in mice. Pharmacol. Biochem. Behav. 51:1995;313-316.
41. 2A receptors in antipsychotic activity. Life Sci. 56:1995;2209-2222.
42. Self D. W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94.
43. 2 modulation of psychostimulant-induced facilitation of brain stimulation reward. Drug Dev. Res. 34:1995;297-305.
44. 2 receptor availability in chronic cocaine abusers. Life Sci. 56:1995;PL299-PL303.
45. Wise R. A. Action of drug of abuse on brain reward system. Pharmacol. Biochem. Behav. (Suppl.). 13:1980;213-223.
46. Wolf W. A., Kuhn D. M. Cocaine and serotonin neurochemistry. Neurochem. Int. 18:1991;33-38.